Presidential Greeting - American Society for Laser Medicine and ...
Presidential Greeting - American Society for Laser Medicine and ...
Presidential Greeting - American Society for Laser Medicine and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
st<strong>and</strong>ardized treatment protocol supervised by a medical director.<br />
Patients received one 30-minute treatment involving low level<br />
laser acupuncture therapy <strong>and</strong> one 30-minute session of<br />
behavioral modification therapy. Follow-up was conducted at 3<br />
months by telephone or email communication to verify patients<br />
were both cigarette <strong>and</strong> nicotine free.<br />
Results: Between 2006 <strong>and</strong> 2009, 357 patients underwent the<br />
treatment protocol. At 3 months, 179 patients were lost to followup.<br />
Of the remaining 178 patients, 40 patients stated they had<br />
relapsed one or more times <strong>and</strong> 138 patients stated they remained<br />
cigarette <strong>and</strong> nicotine free.<br />
Conclusion: Our data show that of all patients treated with<br />
appropriate follow-up, 78% had a successful outcome. In<br />
comparison to leading psychotherapy <strong>and</strong> pharmacotherapy<br />
interventions <strong>for</strong> smoking cessation, one intervention of laser<br />
acupuncture with behavioral modification has similar or better<br />
results at three months. We recommend a multidisciplinary<br />
treatment plan <strong>for</strong> patients to optimize their freedom from<br />
chemical dependency.<br />
#221<br />
META-ANALYSIS OF LASER THERAPY FOR<br />
MELASMA<br />
Shlomit Halachmi, Marete Haedersdal,<br />
Moshe Lapidoth<br />
Rabin Medical Center, Petach Tikva, Israel;<br />
University of Copenhagen, Copenhagen, Denmark<br />
Background: Melasma is a common <strong>and</strong> challenging disorder.<br />
The superficial location of the pigment should make the treatment<br />
amenable to laser therapies. However, the pigmentation is due to<br />
a life-long process of abnormal melanocyte activity <strong>and</strong> is<br />
there<strong>for</strong>e difficult to halt <strong>for</strong> prolonged periods of time by the use<br />
of episodic interventions. Furthermore, melasma is more common<br />
in darker skin, which skin type poses a risk <strong>for</strong> energy-based<br />
interventions. For all these reasons, laser treatments <strong>for</strong> melasma<br />
are a topic of controversy.<br />
Study: A meta-analysis was per<strong>for</strong>med of English language<br />
publications on Medline. Twenty-six studies were identified as<br />
clinical studies in humans. Studies that combined topical<br />
therapies were excluded.<br />
Results: Studies of a wide range of energy-based approaches were<br />
identified, including pigment based (melanin or vascular) lasers,<br />
intense pulsed light, <strong>and</strong> fractional ablative <strong>and</strong> non-ablative<br />
lasers. Of the 26, 19 studies demonstrated appreciable efficacy in<br />
improvement of melasma. Duration of response was limited when<br />
reported. Seven studies exhibited results that do not support the<br />
use of lasers or light sources in melasma due to low efficacy, short<br />
duration of effect, or risk of adverse events.<br />
Conclusion: <strong>Laser</strong>s can offer benefit in melasma in certain<br />
patients. However, they are not universally effective, <strong>and</strong> the<br />
effects are in most cases temporary. The non-durable benefit as<br />
well as the risk of adverse events may limit the widespread use of<br />
lasers in melasma.<br />
#222<br />
<strong>American</strong> <strong>Society</strong> <strong>for</strong> <strong>Laser</strong> <strong>Medicine</strong> <strong>and</strong> Surgery Abstracts 65<br />
NEOVASCULARIZATION FOLLOWING FACIAL<br />
SURGERY: POSSIBLE ETIOLOGY AND<br />
TREATMENT<br />
Shlomit Halachmi, Maurice Adatto, Ran Kornowski,<br />
Moshe Lapidoth<br />
Rabin Medical Center, Petach Tikva, Israel; SkinPulse, Geneva,<br />
Switzerl<strong>and</strong><br />
Background: Angiogenesis is an integral part of any wound<br />
healing process. However, following facial surgery the<br />
angiogenic response can be exaggerated <strong>and</strong> result in<br />
telangiectasia. We describe this relatively unknown phenomenon<br />
<strong>and</strong> demonstrate the safety <strong>and</strong> efficacy of long-pulsed 595 nm<br />
pulsed dye laser <strong>for</strong> the treatment of post-surgical facial<br />
telangiectasia.<br />
Study: Sixteen patients (14 women, 2 men) with Fitzpatrick skin<br />
types II to IV who had undergone facelift (11 patients) or Mohs<br />
surgery <strong>for</strong> basal cell carcinoma (5 patients) were studied. All<br />
noticed peri-incisional telangiectasia 2–3 months post-surgery.<br />
Patients underwent 1–3 treatments with pulsed dye laser. Lesion<br />
clearance was evaluated by two specialists on the basis of digital<br />
photographs taken be<strong>for</strong>e the first treatment <strong>and</strong> 2 months after<br />
the last treatment.<br />
Results: All patients had an excellent response (clearance rating<br />
75–100%). Mild transient purpura <strong>and</strong> minimal pain were<br />
present in all patients. No persistent adverse events were<br />
recorded.<br />
Conclusion: Long-pulse pulsed dye laser is a safe, effective, <strong>and</strong><br />
well-tolerated treatment <strong>for</strong> post-surgical facial telangiectasis.<br />
The mechanism underlying post-surgical telangiectasis is unclear<br />
but may include angiogenesis secondary to wound healing<br />
processes, peri- or post-procedural ischemia, surgical<br />
manipulation of the skin, or stretch.<br />
#223<br />
PURPURIC PULSE DYE LASER TREATMENTS OF<br />
ACNE REDUCE LESIONS—A CHART REVIEW<br />
Hadar Lev-Tov, Judith Hellman<br />
Mount Sinai School of <strong>Medicine</strong>, New York, NY; SUNY Downstate<br />
College of <strong>Medicine</strong>, Brooklyn, NY<br />
Background: We report a highly successful acne treatment<br />
modality using light energy, utilizing the 585 pulse dye laser<br />
(PDL). Previous regimens with the 585 PDL were intent on<br />
using non-purpuric settings <strong>and</strong> led to marginal results. We<br />
used settings that deliberately were in the purpuric range, in a<br />
monthly repeating protocol <strong>for</strong> 3–4 times in most cases. This<br />
regimen consistently resulted in significant <strong>and</strong> dramatic<br />
reduction in the severity of acne <strong>and</strong> often led to complete<br />
remission.<br />
Study: We reviewed all charts of patients who had laser<br />
treatment <strong>for</strong> acne between November 2003 <strong>and</strong> November 2009<br />
in our facility. We included in our analysis patients who had no<br />
more than four treatments <strong>and</strong> had pre-operative <strong>and</strong><br />
post-operative pictures. The final number of patients included was<br />
n ¼ 17. Acne severity was determined based on the type <strong>and</strong><br />
number of the lesions. All patients were treated with a 585 nm<br />
PDL with spot size of 7 mm 2 Energy levels ranged from 4.2 to<br />
6.7 J/cm 2 <strong>and</strong> were graded based on patients’ tolerance <strong>and</strong><br />
Fitzpatrick skin type.<br />
Results: Ninety-four percent of patients had significant reduction<br />
in severity of lesions. Based on our scoring system the average<br />
starting score was 4.44 <strong>and</strong> the average score after treatments<br />
was 0.88 (average reduction ¼ 3.6 points). Nine patients<br />
experienced complete remission. Presently, two patients had<br />
sustained the remission <strong>for</strong> over 3 years.<br />
Conclusion: Five hundred eighty-five PDL treatments of acne<br />
with purpuric settings may result in effective <strong>and</strong> lasting<br />
reduction of lesions.